Dr. Kesselheim, who resigned from the agency’s advisory committee, calls this ‘probably the worst drug approval decision in recent US history’

Dr. Aaron Kesselheim had been on an advisory committee for the US Food and Drug Administration for a half-dozen years, but he had never been to a meeting like this one.